# Trial of CF101 to Treat Patients With Dry Eye Disease

> **NCT01235234** · PHASE3 · COMPLETED · sponsor: **Can-Fite BioPharma** · enrollment: 236 (actual)

## Conditions studied

- Keratoconjunctivitis Sicca

## Interventions

- **DRUG:** CF101

## Key facts

- **NCT ID:** NCT01235234
- **Lead sponsor:** Can-Fite BioPharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2013-11
- **Final completion:** 2013-12
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2022-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01235234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01235234, "Trial of CF101 to Treat Patients With Dry Eye Disease". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01235234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*